Evidence grade: WEAK — Supported only by weak or preliminary evidence.
computed from the encoded evidence by the Atlas grading rule.
BraTS drove robust, near-expert automated tumor segmentation (nnU-Net etc.); enables volumetrics at scale
Marginal Dice gains are clinically meaningless; benchmark curation (skull-strip, co-registration, expert consensus labels) does not reflect messy clinical data; volumetric RANO not yet standard
Field effort concentrated on a solved-ish task while measurement standardization for trials lags
This is an educational research resource from Resonant Labs, not clinical advice. Evidence grades and controversies are summarized from the literature and may change as the field evolves.